Peter V. Taberner

1.1k total citations
71 papers, 833 citations indexed

About

Peter V. Taberner is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Peter V. Taberner has authored 71 papers receiving a total of 833 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 22 papers in Physiology. Recurrent topics in Peter V. Taberner's work include Neuroscience and Neuropharmacology Research (28 papers), Adipose Tissue and Metabolism (12 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Peter V. Taberner is often cited by papers focused on Neuroscience and Neuropharmacology Research (28 papers), Adipose Tissue and Metabolism (12 papers) and Metabolomics and Mass Spectrometry Studies (7 papers). Peter V. Taberner collaborates with scholars based in United Kingdom, Taiwan and Spain. Peter V. Taberner's co-authors include Mei‐Fen Shih, G.A. Kerkut, J.T. Rick, R. Kerwin, C Pycock, John Collinge, Martin Pearce, Jeffrey C. Watkins, R.G. Hill and Miles D. Houslay and has published in prestigious journals such as Brain Research, Journal of Neurochemistry and The Journal of the Acoustical Society of America.

In The Last Decade

Peter V. Taberner

69 papers receiving 778 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter V. Taberner United Kingdom 18 418 259 199 93 84 71 833
H. Coper Germany 19 575 1.4× 425 1.6× 190 1.0× 233 2.5× 80 1.0× 124 1.4k
J. Knoll Hungary 17 527 1.3× 380 1.5× 131 0.7× 170 1.8× 39 0.5× 69 1.0k
Theodore A. Hare United States 22 691 1.7× 368 1.4× 208 1.0× 105 1.1× 237 2.8× 46 1.4k
Hakan Kayır Türkiye 18 453 1.1× 330 1.3× 167 0.8× 102 1.1× 87 1.0× 58 904
V.M. Varagić Serbia 17 336 0.8× 348 1.3× 206 1.0× 111 1.2× 48 0.6× 89 935
Gerda I. Klingman United States 15 321 0.8× 242 0.9× 155 0.8× 99 1.1× 35 0.4× 28 679
Toshikatsu Nakashima Japan 18 429 1.0× 492 1.9× 224 1.1× 108 1.2× 42 0.5× 61 1.1k
J R Boissier France 18 584 1.4× 296 1.1× 126 0.6× 109 1.2× 91 1.1× 58 1.1k
John D. Connor United States 21 972 2.3× 482 1.9× 192 1.0× 123 1.3× 94 1.1× 42 1.6k
Toshitaka Nabeshima Japan 15 622 1.5× 290 1.1× 319 1.6× 158 1.7× 48 0.6× 17 1.1k

Countries citing papers authored by Peter V. Taberner

Since Specialization
Citations

This map shows the geographic impact of Peter V. Taberner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter V. Taberner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter V. Taberner more than expected).

Fields of papers citing papers by Peter V. Taberner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter V. Taberner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter V. Taberner. The network helps show where Peter V. Taberner may publish in the future.

Co-authorship network of co-authors of Peter V. Taberner

This figure shows the co-authorship network connecting the top 25 collaborators of Peter V. Taberner. A scholar is included among the top collaborators of Peter V. Taberner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter V. Taberner. Peter V. Taberner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taberner, Peter V., et al.. (2002). Effects of the imidazoline ligands efaroxan and KU14R on blood glucose homeostasis in the mouse. European Journal of Pharmacology. 454(1). 95–102. 17 indexed citations
2.
Taberner, Peter V., et al.. (2000). Homocysteine further augments impaired acetylcholine-stimulated relaxation and cyclic gmp formation in aortae from diabetic rabbits. UCL Discovery (University College London). 1 indexed citations
3.
Shih, Mei‐Fen & Peter V. Taberner. (2000). Changes in adipose tissue hormone-sensitive lipase activity and cAMP during ethanol withdrawal. European Journal of Pharmacology. 409(3). 223–231. 8 indexed citations
4.
Shih, Mei‐Fen, et al.. (2000). Effect of acute and sub-chronic administration of the imidazoline compound S 22068 on in vivo glucose and insulin responses in normal lean CBA/Ca mice. General Pharmacology The Vascular System. 34(3). 183–191. 6 indexed citations
5.
Williams, Christopher, Mei‐Fen Shih, & Peter V. Taberner. (1999). A Simple Acutein VivoComparative Test for Sensitivity to Insulin in the Mouse. Hormone and Metabolic Research. 31(10). 580–582. 8 indexed citations
6.
Shih, Mei‐Fen, et al.. (1999). Sustained improvement in glucose homeostasis in lean and obese mice following chronic administration of the β3 agonist SR 58611A. British Journal of Pharmacology. 128(7). 1586–1592. 15 indexed citations
7.
Shih, Mei‐Fen, et al.. (1998). Diurnal variation in plasma ethanol levels of TO and CBA mice on chronic ethanol drinking or ethanol liquid diet schedules. Psychopharmacology. 138(2). 143–150. 20 indexed citations
8.
Shih, Mei‐Fen & Peter V. Taberner. (1997). Dose‐dependent effects of chronic ethanol on mouse adipose tissue lipase activity and cyclic AMP accumulation. British Journal of Pharmacology. 120(4). 721–727. 10 indexed citations
9.
Shih, Mei‐Fen, et al.. (1996). CHRONIC ETHANOL CONSUMPTION AMELIORATES THE MATURITY-ONSET DIABETES-OBESITY SYNDROME IN CBA MICE. Alcohol and Alcoholism. 31(1). 89–99. 10 indexed citations
10.
Shih, Mei‐Fen & Peter V. Taberner. (1995). Selective activation of brown adipocyte hormone-sensitive lipase and cAMP production in the mouse by β3-adrenoceptor agonists. Biochemical Pharmacology. 50(5). 601–608. 31 indexed citations
11.
Figueroa, Carlos D. & Peter V. Taberner. (1994). Pancreatic islet hypertrophy in spontaneous maturity onset obese-diabetic CBA/Ca mice. International Journal of Biochemistry. 26(10-11). 1299–1303. 11 indexed citations
12.
Palmer, Timothy M., Peter V. Taberner, & Miles D. Houslay. (1992). Alterations in G-protein expression, Gi function and stimulatory receptor-mediated regulation of adipocyte adenylyl cyclase in a model of insulin-resistant diabetes with obesity. Cellular Signalling. 4(4). 365–377. 24 indexed citations
13.
Mercer, Stewart W, Richard M. Denton, & Peter V. Taberner. (1992). The development of resistance to the lipogenic effects of insulin in brown and white adipose tissue of spontaneously type II diabetic male CBA/CA mice. International Journal of Biochemistry. 24(6). 941–944. 4 indexed citations
14.
Taberner, Peter V., et al.. (1991). Reduced insulin binding to liver plasma membranes in inherently obese diabetic CBA/CA mice. Biochemical Pharmacology. 41(5). 729–733. 3 indexed citations
15.
Taberner, Peter V.. (1989). A SOURCE OF ERROR IN BLOOD ALCOHOL ANALYSIS. Alcohol and Alcoholism. 3 indexed citations
16.
Taberner, Peter V.. (1989). The GABA system in functional tolerance and dependence following barbiturates, benzodiazepines or ethanol—correlation or causality?. Comparative Biochemistry and Physiology Part A Physiology. 93(1). 241–245. 7 indexed citations
17.
Taberner, Peter V., et al.. (1989). Characterization of the spontaneous diabetes obesity syndrome in mature male CBA/Ca mice. Pharmacology Biochemistry and Behavior. 34(2). 255–259. 13 indexed citations
18.
Taberner, Peter V., et al.. (1980). Studies on the hypnotic effects of chloral hydrate and ethanol and their metabolism in vivo and in vitro. Biochemical Pharmacology. 29(21). 3011–3016. 20 indexed citations
19.
Taberner, Peter V., et al.. (1978). The anticonvulsant action of L-2,4-diaminobutyric acid. European Journal of Pharmacology. 52(3-4). 281–286. 12 indexed citations
20.
Taberner, Peter V., J.T. Rick, & G.A. Kerkut. (1972). Metabolic factors involved in the interaction between pyrazole and butane-1, 4-diol and 4-hydroxybutyric acid. Life Sciences. 11(7). 335–341. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Coper Breakdown of academic impact, for papers by J. Knoll Breakdown of academic impact, for papers by Theodore A. Hare Breakdown of academic impact, for papers by Hakan Kayır Breakdown of academic impact, for papers by V.M. Varagić Breakdown of academic impact, for papers by Gerda I. Klingman Breakdown of academic impact, for papers by Toshikatsu Nakashima Breakdown of academic impact, for papers by J R Boissier Breakdown of academic impact, for papers by John D. Connor Breakdown of academic impact, for papers by Toshitaka Nabeshima
Rankless by CCL
2026